Stock Financial Ratios

PAHC / Phibro Animal Health Corporation financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price38.35
Volume213,200.00
Market Cap ($M)1,477.32
Enterprise Value ($M)1,721.48
Book Value ($M)151.16
Book Value / Share3.77
Price / Book9.06
NCAV ($M)-108.58
NCAV / Share-2.71
Price / NCAV-13.36
Income Statement (mra) ($M)
Revenue764.28
EBITDA97.93
Net Income64.61
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets369.45
Liabilities0.00
Quick Ratio1.75
Current Ratio3.14
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.16
Return on Assets (ROA)0.11
Return on Equity (ROE)0.71
Identifiers and Descriptors
CUSIP71742Q106
Central Index Key (CIK)1069899
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
71742Q956
Share Statistics
Preferred Stock Shares Outstanding0
Weighted Average Number Of Diluted Shares Outstanding40,042,000
Common Shares Outstanding220,626,836
Weighted Average Number Of Shares Outstanding Basic39,524,000
Common Shares Outstanding19,261,789
Scoring Models
Piotroski F-Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Cash And Equivalents Per Share0.00
Debt Per Share5.89
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Accounts Payable Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Current Per Share0.00
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Equity Per Share-12.12
Cash Per Share0.00
Assets Per Share9.23
Liabilities Current Per Share2.94
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00

Peers - Pharmaceutical Preparations (2834)

Related News Stories

Phibro Animal Health Corporation 2018 Q2 - Results - Earnings Call Slides

2018-02-07 seekingalpha
The following slide deck was published by Phibro Animal Health Corporation in conjunction with their 2018 Q2 earnings call. (2-0)

Phibro Animal Health's (PAHC) CEO Jack Bendheim on Q2 2018 Results - Earnings Call Transcript

2018-02-06 seekingalpha
Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2018 Results Conference Call February 6, 2018 9:00 AM ET (2-0)

Phibro Animal (PAHC) Beats on Q2 Earnings, Raises Guidance

2018-02-06 zacks
Phibro Animal Health Corporation (PAHC - Free Report) reported adjusted earnings per share (EPS) of 44 cents in the second quarter of fiscal 2018, up 12.8% year over year. Adjusted EPS surpassed the Zacks Consensus Estimate of 39 cents. According to the company, the year-over-year improvement was primarily driven by a higher gross profit ratio, reduced interest expenses and a lower effective income tax rate. (9-0)

Should You Sell Phibro Animal Health (PAHC) Before Earnings?

2018-02-01 zacks
Investors are always looking for stocks that are poised to beat at earnings season and Phibro Animal Health Corporation (PAHC - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. (23-0)

Phibro Will Benefit From Growing Global Demand For Protein-Rich Foods

2017-11-30 seekingalpha
Phibro’s shares currently trade at a wide discount to peers; this gap should close significantly going forward. (2-0)

CUSIP: 71742Q106